![Joseph Sum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Joseph Sum worked as an Analyst at BVF, Inc. from 2007 to 2013, an Engineer at Genentech, Inc. in 2007, a Director at Ziarco Pharma Ltd. in 2012, a Director of Research at EcoR1 Capital, LLC, and a Co-Portfolio Manager & Analyst at First Manhattan Co. in 2013-2014.
He obtained an undergraduate degree from the University of California, Berkeley.
Anciens postes connus de Joseph Sum
| Sociétés | Poste | Fin |
|---|---|---|
First Manhattan Co.
 First Manhattan Co. Investment ManagersFinance FMC seeks to deliver long-term value through an investment approach aligned with clients' goals and driven by in-house, proprietary research. | Analyst-Equity | 01/03/2014 |
BVF, Inc.
 BVF, Inc. Investment Banks/BrokersFinance Manages hedge funds and engages in investment business | Corporate Officer/Principal | 01/03/2013 |
Ziarco Pharma Ltd.
 Ziarco Pharma Ltd. BiotechnologyHealth Technology Provides therapeutics targeting inflammatory and allergic diseases | Directeur/Membre du Conseil | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/07/2007 |
EcoR1 Capital, LLC
 EcoR1 Capital, LLC Investment ManagersFinance EcoR1 invests (long and short) in securities, consisting principally, but not solely, of equity and equity-related securities that are issued by biotechnology companies globally. | Directeur de la Recherche - Actions | - |
Formation de Joseph Sum
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
48
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
First Manhattan Co.
First Manhattan Co. Investment ManagersFinance FMC seeks to deliver long-term value through an investment approach aligned with clients' goals and driven by in-house, proprietary research. | Finance |
BVF, Inc.
BVF, Inc. Investment Banks/BrokersFinance Manages hedge funds and engages in investment business | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ziarco Pharma Ltd.
Ziarco Pharma Ltd. BiotechnologyHealth Technology Provides therapeutics targeting inflammatory and allergic diseases | Health Technology |
EcoR1 Capital, LLC
EcoR1 Capital, LLC Investment ManagersFinance EcoR1 invests (long and short) in securities, consisting principally, but not solely, of equity and equity-related securities that are issued by biotechnology companies globally. | Finance |
